論文

国際誌
2022年12月5日

Feasibility and efficacy of endoscopic reintervention after covered metal stent placement for EUS-guided hepaticogastrostomy: A multicenter experience.

Endoscopic ultrasound
  • Kosuke Minaga
  • Masayuki Kitano
  • Yoshito Uenoyama
  • Keiichi Hatamaru
  • Hideyuki Shiomi
  • Kenji Ikezawa
  • Tsukasa Miyagahara
  • Hajime Imai
  • Nao Fujimori
  • Hisakazu Matsumoto
  • Yuzo Shimokawa
  • Atsuhiro Masuda
  • Mamoru Takenaka
  • Masatoshi Kudo
  • Yasutaka Chiba
  • 全て表示

記述言語
英語
掲載種別
研究論文(学術雑誌)
DOI
10.4103/EUS-D-22-00029

BACKGROUND AND OBJECTIVES: Although the use of a long metal stent is favored for EUS-guided hepaticogastrostomy (EUS-HGS) for the relief of malignant biliary obstruction (MBO), endoscopic reintervention (E-RI) at the time of recurrent biliary obstruction (RBO) is challenging due to a long intragastric portion. This study evaluated the feasibility and safety of E-RI after a long partially covered metal stent (L-PCMS) placement during EUS-HGS. MATERIALS AND METHODS: We performed a multicenter retrospective study between January 2015 and December 2019 examining patients with MBO who underwent E-RI for RBO through the EUS-HGS route after the L-PCMS placement. Technical and clinical success rates, details of E-RI, adverse events (AEs), stent patency, and survival time were evaluated. RESULTS: Thirty-three patients at eight referral centers in Japan who underwent E-RI through the EUS-HGS route were enrolled. The location of MBO was distal in 54.5%. The median intragastric length of the L-PCMS was 5 cm. As the first E-RI attempt, E-RI via the distal end of the existing L-PCMS was successful in 60.6%. The overall technical and clinical success rates of E-RI were 100% and 81.8%, respectively. Liver abscess was noted in one patient. A proximal biliary stricture was associated with the clinical ineffectiveness of E-RI in multivariable analysis (odds ratio, 12.5, P = 0.04). The median survival and stent patency duration after E-RI were 140 and 394 days, respectively. CONCLUSIONS: Our study findings suggest that E-RI for RBO after EUS-HGS with a L-PCMS is technically feasible and clinically effective, without any severe AEs, especially for patients with distal MBO.

リンク情報
DOI
https://doi.org/10.4103/EUS-D-22-00029
PubMed
https://www.ncbi.nlm.nih.gov/pubmed/36510878
ID情報
  • DOI : 10.4103/EUS-D-22-00029
  • PubMed ID : 36510878

エクスポート
BibTeX RIS